<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>SUMMARY: This study aimed to develop a new model of colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> (LM) in the rat </plain></SENT>
<SENT sid="1" pm="."><plain>Both single macroscopic and multiple bilobar microscopic LM were investigated, as this closely resembled the human situation, before right hepatectomy was performed for 'single' right LM </plain></SENT>
<SENT sid="2" pm="."><plain>The single macroscopic LM was elicited by direct injection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DHD</z:e>/K12 <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells under the capsule of the median liver lobe in immunocompetent BDIX rats </plain></SENT>
<SENT sid="3" pm="."><plain>The bilobar micrometastases were elicited by intraportal injection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DHD</z:e>/K12 cells </plain></SENT>
<SENT sid="4" pm="."><plain>A preliminary protocol was conducted to assess the dose of cells required to inject in to the portal vein, using 10(6) , 2 × 10(6) and 3 × 10(6) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DHD</z:e>/K12 cells (n = 15 rats) </plain></SENT>
<SENT sid="5" pm="."><plain>The resultant protocol for the experimental model used intraportal injection of 10(6) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DHD</z:e>/K12 cells and direct injections of 0.5 × 10(6) , 10(6) and 1.5 × 10(6) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DHD</z:e>/K12 cells (n = 15 rats) </plain></SENT>
<SENT sid="6" pm="."><plain>For both protocols, BDIX rats were sacrificed at day 30 after injection </plain></SENT>
<SENT sid="7" pm="."><plain>The preliminary protocol showed that intraportal injection of 10(6) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DHD</z:e>/K12 cells was associated with bilobar micrometastases of 0.8 mm mean diameter at day 30 </plain></SENT>
<SENT sid="8" pm="."><plain>The main protocol assessed that direct injection of 0.5 × 10(6) under the liver median lobe capsule and intraportal injection of 10(6) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DHD</z:e>/K12 cells were associated at day 30 with a single macroscopic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> confined to a liver lobe and bilobar micrometastases, without <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> or lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Thus we have developed a new experimental model of bilobar colorectal LM including both macro- and microscopic colorectal LMs, which mimics the human situation and which will be useful in preclinical studies </plain></SENT>
</text></document>